Pipeline Previews

By No Comments
JUVÉDERM VOLUMAAllergan, Inc., has announced that it has received approval from the FDA to market the filler JUVÉDERM VOLUMA™ XC to temporarily correct age-related volume loss in the cheek area…
Read More

Clinical Trial Review

By No Comments
Ph 3, Prospective, Open-Label, Multicenter Study of Lymphoseek Sponsored by Navidea Biopharmaceuticals, the purpose of this study is to determine the false negative rate (FNR) associated with Lymphoseek-identified sentinel lymph…
Read More

T-Cell Plasticity of Dapsone and DRESS

By No Comments
INTRODUCTION We report a case of dapsone hypersensitivity syndrome in a 42-year-old Chinese woman with borderline lepromatous leprosy that included life-threatening hypersensitivity pneumonitis and fulminant hepatitis. Zhang’s1 and Wang’s2 recent…
Read More